| 07th week of 2018 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20180042869 | THERAPEUTIC AGENTS FOR USE IN THE PROPYLAXIS AND/OR TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS | 2018-02-15 |
| 20180042870 | USE OF CYSTEAMINE AND DERIVATIVES THEREOF TO SUPPRESS TUMOR METASTASES | 2018-02-15 |
| 20180042871 | BICYCLIC ANALGESIC COMPOUNDS | 2018-02-15 |
| 20180042872 | METHODS FOR TREATING MALARIA USING POTASSIUM CHANNEL INHIBITORS | 2018-02-15 |
| 20180042873 | NOVEL METHODS | 2018-02-15 |
| 20180042874 | METHOD FOR TREATING OSTEOPOROSIS | 2018-02-15 |
| 20180042875 | COMPOUND USE IN PROMOTING ENERGY EXPENDITURE | 2018-02-15 |
| 20180042876 | INHALATION FORMULATIONS OF TREPROSTINIL | 2018-02-15 |
| 20180042877 | Solid Solution Compositions and Use in Chronic Inflammation | 2018-02-15 |
| 20180042878 | SOLID PREPARATION INCLUDING ANTIOXIDANT | 2018-02-15 |
| 20180042879 | FREE AMINO ACID PREPARATION AND USES THEREOF | 2018-02-15 |
| 20180042880 | METHODS OF TREATING MIXED DYSLIPIDEMIA | 2018-02-15 |
| 20180042881 | PRODRUGS OF FUMARATES AND THEIR USE IN TREATING VARIOUS DISEASES | 2018-02-15 |
| 20180042882 | C16:1n7-PALMITOLEATE AND DERIVATIVES THEREOF FOR TREATING OBESITY, PROMOTING WEIGHT LOSS, AND SUPPORTING WEIGHT MANAGEMENT | 2018-02-15 |
| 20180042883 | COMPOSITIONS AND METHODS FOR LOWERING LEVELS OF HIGH-SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IN A SUBJECT | 2018-02-15 |
| 20180042884 | COMPOSITIONS FOR USE IN TREATING GLIOBLASTOMA | 2018-02-15 |
| 20180042885 | METHOD FOR TREATING AUTISM AND OTHER NEURODEVELOPMENTAL DISORDERS | 2018-02-15 |
| 20180042886 | METHODS OF TREATING AGE RELATED DISORDERS | 2018-02-15 |
| 20180042887 | COMBINATION TREATMENT PROTOCOL | 2018-02-15 |
| 20180042888 | MONENSIN WATER DISPERSIBLE GRANULES BY WET GRANULATION | 2018-02-15 |
| 20180042889 | METHOD FOR TREATING TAU-ASSOCIATED DISEASES USING TETRAHYDROPYRANOL DERIVATIVES | 2018-02-15 |
| 20180042890 | CANNABIS-BASED EXTRACTS AND TOPICAL FORMULATIONS FOR USE IN SKIN DISORDERS | 2018-02-15 |
| 20180042891 | Cancer Cell Apoptosis | 2018-02-15 |
| 20180042892 | PHARMACEUTICAL COMPOSITION CONTAINING SILIBININ | 2018-02-15 |
| 20180042893 | PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN | 2018-02-15 |
| 20180042894 | EYE HEALTH COMPOSITION | 2018-02-15 |
| 20180042895 | TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY A BETA-BLOCKER | 2018-02-15 |
| 20180042896 | USE OF AMISULPRIDE AS AN ANTI-EMETIC | 2018-02-15 |
| 20180042897 | IPA AS A PROTECTIVE AGENT | 2018-02-15 |
| 20180042898 | V1B RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF PATIENTS HAVING AN ELEVATED AVP LEVEL AND/OR AN ELEVATED COPEPTIN LEVEL | 2018-02-15 |
| 20180042899 | Method of Treating Transplant Rejection and Autoimmune Diseases | 2018-02-15 |
| 20180042900 | Compositions and Methods employing Wolbachia FtsZ as a target for Albendazole sulfone | 2018-02-15 |
| 20180042901 | DRUG COMPOSITIONS COMPRISING AN ANTI-PARASITIC AND PROTON PUMP INHIBITOR | 2018-02-15 |
| 20180042902 | Heterocyclic Compounds and Uses Thereof | 2018-02-15 |
| 20180042903 | METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS | 2018-02-15 |
| 20180042904 | COMPOSITIONS AND METHODS FOR TREATING COPD AND OTHER INFLAMMATORY CONDITIONS | 2018-02-15 |
| 20180042905 | METHODS OF TREATING HEPATITIS B VIRUS | 2018-02-15 |
| 20180042906 | PHARMACEUTICAL COMPOSITIONS | 2018-02-15 |
| 20180042907 | SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION | 2018-02-15 |
| 20180042908 | PHENYL DERIVATIVE | 2018-02-15 |
| 20180042909 | Methods of Treating Cancers, Autoimmune Disorders, and Other Conditions Associated with Chronic Inflammation | 2018-02-15 |
| 20180042910 | THERAPEUTIC AGENT FOR FRONTAL LOBE DYSFUNCTION | 2018-02-15 |
| 20180042911 | OPHTHALMIC COMPOSITION | 2018-02-15 |
| 20180042912 | MEDICAL PRODUCT AND METHOD FOR ELIMINATING SYMPTOMS OF NICOTINE WITHDRAWAL | 2018-02-15 |
| 20180042913 | USE OF LAQUINIMOD TO DELAY HUNTINGTON'S DISEASE PROGRESSION | 2018-02-15 |
| 20180042914 | BROMODOMAIN INHIBITOR | 2018-02-15 |
| 20180042915 | Treatment of Retinopathy of Prematurity (ROP) | 2018-02-15 |
| 20180042916 | TREATMENT OF MULTIPLE SCLEROSIS WITH LAQUINIMOD | 2018-02-15 |
| 20180042917 | COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING METABOLIC DISEASES, CONTAINING AMODIAQUINE AS ACTIVE INGREDIENT | 2018-02-15 |
| 20180042918 | RESPIRATORY INFECTION TREATING AGENT | 2018-02-15 |
| 20180042919 | PARP Inhibitors for the Treatment of Major Depressive Disorder and Related Conditions | 2018-02-15 |
| 20180042921 | METHOD OF TREATING A BRAIN TUMOR | 2018-02-15 |
| 20180042922 | COMPOSITIONS AND METHODS OF TREATING A NEURODEGENERATIVE DISEASE | 2018-02-15 |
| 20180042923 | COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER | 2018-02-15 |
| 20180042924 | PHARMACEUTICAL FORMULATIONS, PROCESSES, SOLID FORMS AND METHODS OF USE RELATING TO 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL)PYRIDIN-3-YL)-3,4-DIHYDROPYR- AZINO[2,3-b]PYRAZIN-2(1H)-ONE | 2018-02-15 |
| 20180042925 | METHODS FOR TREATING CANCER | 2018-02-15 |
| 20180042926 | DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS | 2018-02-15 |
| 20180042927 | PHOSPHODIESTERASE INHIBITORS TO REPAIR BRAIN AND/OR RETINAL INJURY IN HUMAN NEWBORNS | 2018-02-15 |
| 20180042928 | METHODS AND COMPOSITIONS FOR TREATING BACTERIAL INFECTION | 2018-02-15 |
| 20180042929 | USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES | 2018-02-15 |
| 20180042930 | METHODS OF TREATMENT OF MALIGNANCIES | 2018-02-15 |
| 20180042931 | N-PHENYL-(MORPHOLIN-4-YL OR PIPERAZINYL)ACETAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE WNT SIGNALLING PATHWAYS | 2018-02-15 |
| 20180042932 | COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE | 2018-02-15 |
| 20180042933 | TREATMENT OF ACVR1-MEDIATED DISEASES | 2018-02-15 |
| 20180042934 | BIARYL COMPOSITIONS AND METHODS FOR MODULATING A KINASE CASCADE | 2018-02-15 |
| 20180042935 | THERAMUTEIN MODULATORS | 2018-02-15 |
| 20180042936 | MAINTENANCE THERAPY USING TIANEPTINE | 2018-02-15 |
| 20180042937 | NOVEL ANTIVIRAL COMPOSITIONS FOR TREATING THE FLU | 2018-02-15 |
| 20180042938 | NOVEL COMPOSITIONS OF COMBINATIONS OF NON-COVALENT DNA BINDING AGENTS AND ANTI-CANCER AND/OR ANTI-INFLAMMATORY AGENTS AND THEIR USE IN DISEASE TREATMENT | 2018-02-15 |
| 20180042939 | DOSING REGIMEN FOR SEDATION WITH CNS 7056 (REMIMAZOLAM) | 2018-02-15 |
| 20180042940 | SOFT LOZENGE COMPOSITIONS | 2018-02-15 |
| 20180042941 | CABAZITAXEL AND ITS USE FOR TREATING METASTATIC PROSTATE CANCERS | 2018-02-15 |
| 20180042942 | Compounds that are Analogs of Squalamine, Used as Antibacterial Agents | 2018-02-15 |
| 20180042943 | METHODS FOR MODULATING BONE DENSITY | 2018-02-15 |
| 20180042944 | PHARMACEUTICAL COMPOSITIONS | 2018-02-15 |
| 20180042945 | METABOLIC SYNDROME TREATMENT | 2018-02-15 |
| 20180042946 | TOPICAL ANTIVIRAL FORMULATIONS | 2018-02-15 |
| 20180042947 | NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | 2018-02-15 |
| 20180042948 | BORON-DIPYRRIN COMPLEX AND MEDICAMENT CONTAINING THE SAME | 2018-02-15 |
| 20180042949 | COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF OTITIS OR BRONCHITIS IN INFANTS OR YOUNG CHILDREN | 2018-02-15 |
| 20180042950 | METHODS FOR REDUCING THE INCIDENCE OF OXIDATIVE STRESS USING HUMAN MILK OLIGOSACCHARIDES, VITAMIN C AND ANTI-INFLAMMATORY AGENTS | 2018-02-15 |
| 20180042951 | GLUCOCEREBROSIDE TREATMENT OF LIVER DISORDERS | 2018-02-15 |
| 20180042952 | ETOPOSIDE AND PRODRUGS THEREOF FOR USE IN TARGETING CANCER STEM CELLS | 2018-02-15 |
| 20180042953 | ANTIBACTERIAL INJECTABLE PHARMACEUTICAL COMPOSITION | 2018-02-15 |
| 20180042954 | URLC10-DERIVED PEPTIDE AND VACCINE CONTAINING SAME | 2018-02-15 |
| 20180042955 | UNIT STRUCTURE-TYPE PHARMACEUTICAL COMPOSITION FOR NUCLEIC ACID DELIVERY | 2018-02-15 |
| 20180042956 | Glutamate Dehydrogenase 1 Inhibitors and Methods of Treating Cancer | 2018-02-15 |
| 20180042957 | POLYMER MATRIX COMPOSITIONS COMPRISING A HIGH CONCENTRATION OF BIO-FERMENTED SODIUM HYALURONATE AND USES THEREOF | 2018-02-15 |
| 20180042958 | GALACTOSE-PRONGED POLYSACCHARIDES IN A FORMULATION FOR ANTIFIBROTIC THERAPIES | 2018-02-15 |
| 20180042959 | GLUCOCEREBROSIDE TREATMENT OF DISEASE | 2018-02-15 |
| 20180042960 | IRON CARBOHYDRATE COMPLEX FOR TREATMENT OF RESTLESS LEG SYNDROME (RLS) | 2018-02-15 |
| 20180042961 | COMPOSITION AND METHOD FOR ALTERING HAIR PIGMENTATION | 2018-02-15 |
| 20180042962 | Vascular Calcification Prevention and Treatment | 2018-02-15 |
| 20180042963 | CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF | 2018-02-15 |
| 20180042964 | Cell Preparations For Extemporaneous Use, Useful For Healing And Rejuvenation In Vivo | 2018-02-15 |
| 20180042965 | ISOLATED POPULATIONS OF RENAL STEM CELLS AND METHODS OF ISOLATING AND USING SAME | 2018-02-15 |
| 20180042966 | USE OF MESENCHYMAL STEM CELLS IN TREATING OSTEOARTHRITIS | 2018-02-15 |
| 20180042967 | METHOD FOR REDUCING THE INFLAMMATORY ACTIVITY OF A STEM CELL TRANSPLANT AND USE THEREOF | 2018-02-15 |
| 20180042968 | HUMAN CORD BLOOD AS A SOURCE OF NEURAL TISSUE REPAIR OF THE BRAIN AND SPINAL CORD | 2018-02-15 |
| 20180042969 | COMPOSITIONS AND METHODS FOR THE REPROGRAMMING OF CELLS INTO CARDIOMYOCYTES | 2018-02-15 |
